Literature DB >> 17515549

Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Marcelo E Bigal1, Richard B Lipton, Philip R Holland, Peter J Goadsby.   

Abstract

Migraine and obesity are associated in several ways. First, both are prevalent and disabling disorders influenced by genetic and environmental risk factors. Second, migraine with aura, as obesity, seems to be a risk factor for cardiovascular events. Finally, large population-based studies suggest that obesity is a risk factor for chronic migraine after adjusting for comorbidities. In this article, we discuss plausible mechanisms that may account for this association. Several of the inflammatory mediators that are increased in obese individuals are important in migraine pathophysiology, including interleukins and calcitonin gene-related peptide (CGRP). These mediators may increase the frequency, severity, and duration of migraine attacks per se, which in turn would cause central sensitization. Repeated central sensitization may be associated with permanent neuronal damage close to the periaqueductal gray area, with poor modulation to pain. Obesity is also a state of sympathetic activation, which may contribute to increase in headache frequency. Furthermore, the levels of adiponectin are decreased in obesity. At low but not normal levels, adiponectin is nociceptive. Shared biologic predisposition may also play a major role. Orexins modulate both pain and metabolism. Dysfunction in the orexins pathways seems to be a risk factor for both conditions. Finally, conditions that are comorbid to both states (e.g., depression, sleep apnea) may also make the relationship between both diseases more complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515549     DOI: 10.1212/01.wnl.0000262045.11646.b1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  85 in total

Review 1.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Chronic daily headache, medication overuse, and obesity in children and adolescents.

Authors:  Ann Pakalnis; Donna Kring
Journal:  J Child Neurol       Date:  2011-09-27       Impact factor: 1.987

Review 3.  Migraine and cardiovascular diseases.

Authors:  G Pierangeli; G Giannini; V Favoni; L Sambati; S Cevoli; P Cortelli
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

4.  Non-alcoholic fatty liver disease in patients with migraine.

Authors:  Asuman Celikbilek; Mehmet Celikbilek; Aylin Okur; Serkan Dogan; Elif Borekci; Mustafa Kozan; Sebnem Gursoy
Journal:  Neurol Sci       Date:  2014-04-23       Impact factor: 3.307

Review 5.  Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment.

Authors:  D S Bond; J Roth; J M Nash; R R Wing
Journal:  Obes Rev       Date:  2011-05       Impact factor: 9.213

6.  Body mass index, migraine, migraine frequency and migraine features in women.

Authors:  A C Winter; K Berger; J E Buring; T Kurth
Journal:  Cephalalgia       Date:  2009-02       Impact factor: 6.292

Review 7.  Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm.

Authors:  Vincenzo Bonavita; Roberto De Simone; Angelo Ranieri
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

8.  Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial.

Authors:  Dale S Bond; Kevin C O'Leary; J Graham Thomas; Richard B Lipton; George D Papandonatos; Julie Roth; Lucille Rathier; Richard Daniello; Rena R Wing
Journal:  Contemp Clin Trials       Date:  2013-03-22       Impact factor: 2.226

9.  Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial.

Authors:  Kadriye Alpay; Mustafa Ertas; Elif Kocasoy Orhan; Didem Kanca Ustay; Camille Lieners; Betül Baykan
Journal:  Cephalalgia       Date:  2010-03-10       Impact factor: 6.292

Review 10.  The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis.

Authors:  Dilli Poudel; Michael D George; Joshua F Baker
Journal:  Curr Rheumatol Rep       Date:  2020-08-01       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.